Annual Report FY2526

Date: 03.09.2026 Department of Corporate Services, BSE Limited, Phiroze Jeejeebhoy Towers, Dalal Street, Fort, Mumbai – 400 001. Ref: Scrip Code: 526075 Sub: Announcement under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Dear Sir/Madam, Pursuant to Regulation 30 and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that a Meeting of the Board of Directors of company held on Thursday, 03rd September, 2026, inter alia, to consider and approved: 1. Notice of the ensuing Annual General Meeting of the Company. 2. Annual Report of the Company for the Financial Year 2025–26 3. Appointment of M/s S. Bhattbhatt & Co. (C.O.P. No: 10427), Practicing Company Secretary as Scrutinizer for monitoring the E-voting process. 4. Appointment of M/s. Hetanshi Shah & Associates (FRN: 133646W) as an Internal Auditor of the company. 5. Took note on resignation of Mr. Deepak Khandelwal as a Company Secretary and Compliance Officer w.e.f. closing of business hour of 02nd September, 2026. The time of commencement of Board Meeting was 14:00 and the time of conclusion was 15:10 We request you to kindly take the same in your record. Thanking you, For Rekvina Laboratories Limited Chairman and Executive Director Surbhit Shah DIN: 01993300 CIN: L24231GJ1988PLC01145 Regd. Office: 36, Sampatrao Colony, Next to Royal Hotel, Alkapuri, Baroda -39007 Email Id: info@rekvinalaboratories.com, rekvinalimited@gmail.com Cont. No.: 0265-2362966 38TH ANNUAL REPORT 2025-2026 REKVINA LABORATORIES LIMITED INDEX Sr. No. Contents Page Nos. 1. Notice of AGM 04 2. Board’s Report 11 3. Management Discussion and Analysis Report 22 4. Secretarial Audit Report 26 5. Independent Auditors’ Report 29 6. Balance Sheet 37 7. Statement of Profit & Loss 38 8 Cash flow Statement 39 9 Notes to Balance Sheet 40 CORPORATE INFORMATION BOARD OF DIRECTORS/KMP Mr. Amit Mukesh Shah : Managing Director Mr. Surbhit Shah : Executive Director & Chief Financial Officer Mr. Dhruvalkumar Patel : Independent Director (upto 09.01.2026) Mr. Chetanbhai Patel : Independent Director (upto 29.01.2026) Mrs. Ilaben Pathak : Non-Executive Non-Independent Director Mr. Deepak Khandelwal : Company Secretary & Compliance Mr. Jay Chintan Patel : Independent Director (w.e.f. 29.01.2026) Mr. Prateek Satishkumar Jain : Independent Director (w.e.f. 06.10.2025) REGISTERED OFFICE : 36, Sampatrao Colony, Next to Royal Hotel, Alkapuri, Vadodara, Gujarat, 390007. Email ID: info@rekvinalaboratories.com, Phone: 0265-2362966,2362319 REGISTRAR AND TRANSFER AGENT STATUTORY AUDITORS Purva Share Registry (India) Private Limited Y. M. Shah & Co Unit No. 9, Shiv Shakti Industrial Estate, 3rd floor,Tower A, Atlantis K-10 Lower Parel (E), Mumbai, Maharashtra- 400011. Sarabhai main road, Vadodara-390007. Email Id: purvashr@gmail.com Email ID: shilp_yog@hotmail,com SECRETARIAL AUDITOR INTERNAL AUDITOR S Bhattbhatt & Co. Hetanshi Shah & Associates 520, Grand K10, Sarabhai Road, 988/16/2 GIDC Estate, Vadodara – 390007. Makarpura, Vadodara – 390010 Email id: sbhattbhattco@gmail.com Email: cahetanshishah@gmail.com NOTICE Notice is hereby given that the 38th Annual General Meeting of the Members of Rekvina Laboratories Limited will be held on Tuesday, the 29th day of September, 2026, at 02:30 P.M. through online mode for the financial year 2025-26 to transact the following business as: ORDINARY BUSINESS 1. To consider and adopt the Audited Financial Statement of the Company for the Financial Year ended March 31, 2026 along with the reports of the Board of Directors and Auditors thereon and in this regard to consider and if thought fit, to pass, with or without modification(s), the following resolutions as an Ordinary Resolution: “RESOLVED THAT the Audited Financial Statement of the Company for the Financial Year ended March 31, 2026, along with the reports of the Board of Directors and Auditors thereon laid before this meeting, be and are hereby considered and adopted.” 2. To appoint a director in place of Mrs. Ilaben Pathak (DIN: 01328714), who retires by rotation and being eligible, offers herself for re-appointment. "RESOLVED THAT pursuant to the provisions of Section 152 of the Companies Act, 2013, Mrs. Ilaben Pathak (DIN: 01328714), who retires by rotation at this meeting and being eligible has offered herself for re- appointment, be and is hereby re-appointed as a Director of the company, liable to retire by rotation." SPECIAL BUSINESS 3. APPOINTMENT OF MR. PRATEEK JAIN (DIN: 08611660) AS AN INDEPENDENT DIRECTOR To consider and, if thought fit, to pass the following resolution as a Special Resolution: “RESOLVED THAT pursuant to the provisions of Sections 149, 150, 152 and other applicable provisions of the Companies Act, 2013 (“Act”) read with Schedule IV to the Act and the Companies (Appointment and Qualification of Directors) Rules, 2014, and the applicable provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended from time to time, and based on the recommendation of the Nomination and Remuneration Committee and the Board of Directors, the consent of the Members be and is hereby accorded for the appointment of Mr. Prateek Jain (DIN: 08611660) as an Independent Director of the Company, who was appointed by the Board of Directors with effect from 06th October, 2025, for a term of five consecutive years commencing from 06th October, 2025, and whose office shall not be liable to retire by rotation. RESOLVED FURTHER THAT the Board of Directors of the Company be and is hereby authorised to do all such acts, deeds, matters and things as may be necessary, proper or expedient to give effect to this resolution.” 4. APPOINTMENT OF MR. JAY CHINTAN PATEL (DIN: 10147916) AS AN INDEPENDENT DIRECTOR To consider and, if thought fit, to pass the following resolution as a Special Resolution: “RESOLVED THAT pursuant to the provisions of Sections 149, 150, 152 and other applicable provisions of the Companies Act, 2013 (“Act”) read with Schedule IV to the Act and the Companies (Appointment and Qualification of Directors) Rules, 2014, and the applicable provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended from time to time, and based on the recommendation of the Nomination and Remuneration Committee and the Board of Directors, the consent of the Members be and is hereby accorded for the appointment of Mr. Jay Chintan Patel (DIN: 10147916) as an Independent Director of the Company, who was appointed by the Board of Directors with effect from 09th January, 2026, for a term of five consecutive years commencing from 09th January, 2026, and whose office shall not be liable to retire by rotation. RESOLVED FURTHER THAT the Board of Directors of the Company be and is hereby authorised to do all such acts, deeds, matters and things as may be necessary, proper or expedient to give effect to this resolution.” By order of the Board of Directors For Rekvina Laboratories Limited SD/- Surbhit Shah Chairman and Director DIN No: 01993300 Place: Vadodara Date:03/09/2026 NOTES: 1. Ministry of Corporate Affairs (“MCA”) vide its General Circulars Nos. 14/2020 dated 08th April, 2020, 17/2020 dated 13th April, 2020, 20/2020 dated 05th May, 2020, 9/2023 dated 25th September, 2023, 09/2024 dated 19th September, 2024 and subsequent circulars issued in this regard, the latest being Circular No. 03/2025 dated 22nd September, 2025 (‘MCA Circulars’) and Circular No. SEBI/HO/CFD/CMD1/CIR /P/2020/79, SEBI/HO/CFD/CMD2/CIR/P/2021/11,SEBI/HO/CFD/CMD2/CIR/P/2022/62,SEBI/HO/CFD/CFD PoD2/P/CIR/2023/167 and SEBI/HO/CFD/CFD-PoD-2/P/ CIR/2024/1 33 dated 12th May, 2020, 15th January, 2021, 13th May, 2022, 05th January, 2023, 07th October, 2023 and 03rd October, 2024 respectively issued by Securities and Exchange Board of India (hereinafter collectively referred to as “the Circulars”), has permitted the ho [Showing first 8,000 characters — download PDF for full document]